Related Experiment Video
Updated: Feb 10, 2026

Delivery of Antibodies into the Murine Brain via Convection-enhanced Delivery
Published on: July 18, 2019
Antibody-mediated neutralization of perfringolysin o for intracellular protein delivery
Nicole J Yang1,2, David V Liu1,2, Demetra Sklaviadis3
1†Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States.
Abstract:
Perfringolysin O (PFO) is a member of the cholesterol-dependent cytolysin (CDC) family of bacterial pore-forming proteins, which are highly efficient in delivering exogenous proteins to the cytoplasm. However, the indiscriminate and potent cytotoxicity of PFO limits its practical use as an intracellular delivery system. In this study, we describe the design and engineering of a bispecific, neutralizing antibody against PFO, which targets reversibly attenuated PFO to endocytic compartments via receptor-mediated internalization. This PFO-based system efficiently mediated the endosomal release of a co-targeted gelonin construct with high specificity and minimal toxicity in vitro. Consequently, the therapeutic window of PFO was improved by more than 5 orders of magnitude. Our results demonstrating that the activity of pore-forming proteins can be controlled by antibody-mediated neutralization present a novel strategy for utilizing these potent membrane-lytic agents as a safe and effective intracellular delivery vehicle.
Insights
Engineered antibodies neutralize perfringolysin O (PFO), a bacterial toxin, enabling targeted protein delivery into cells. This innovation significantly enhances PFO
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Background:
- Perfringolysin O (PFO) is a potent bacterial pore-forming protein.
- PFO's cytotoxicity limits its use for intracellular delivery.
- Cholesterol-dependent cytolysins (CDCs) are a family of bacterial proteins.
Purpose of the Study:
- To engineer a bispecific antibody to neutralize PFO.
- To develop a targeted intracellular delivery system using attenuated PFO.
- To improve the safety and efficacy of PFO as a delivery vehicle.
Main Methods:
- Design and engineering of a bispecific, neutralizing antibody against PFO.
- Targeting reversibly attenuated PFO to endocytic compartments via receptor-mediated internalization.
- Co-targeting a gelonin construct with the PFO-antibody system for endosomal release.
Main Results:
- The PFO-based system achieved efficient endosomal release of a gelonin construct.
- High specificity and minimal toxicity were observed in vitro.
- The therapeutic window of PFO was improved by over 5 orders of magnitude.
Conclusions:
- Antibody-mediated neutralization can control the activity of pore-forming proteins.
- This strategy enables the safe and effective use of PFO for intracellular delivery.
- The engineered system presents a novel approach for targeted protein delivery.
Related Concept Videos
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Intracellular Signaling Cascades
Acids, Bases and Neutralization Reactions
Acids, Bases and Neutralization Reactions
Receptor-mediated Endocytosis
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...

